Lyme disease vaccine (recombinant OspA)

Identification

Name
Lyme disease vaccine (recombinant OspA)
Accession Number
DB00045 / TA735GI14L
Groups
Description

Vaccine in opposition to Lyme sickness that carries lipoprotein OspA, an outer surface protein of Borrelia burgdorferi sensu stricto ZS7, as expressed with the aid of Escherichia coli. Lipoprotein OspA is a unmarried polypeptide chain of 257 amino acids with lipids covalently bonded to the N terminus. it's far conjugated with alum (aluminum hydroxide) as an adjuvant.

Pharmacology

Pharmacodynamics

OspA lipoprotein is a single polypeptide chain of 270 amino acids. It is a vaccination used to prevent Lyme Disease.

Indication

For prophylactic treatment of Lyme Disease

Action

OspA lipoprotein, an outer surface protein of the bacteria Borrelia burgdorferi sensu stricto ZS7, is used to stimulate the production of specific antibodies against B. burgdorferi. It is used as a vaccination against Lyme Disease, a disease carried by ticks.